Dr Christoph Neumann analyses the Global Biodiversity Framework Target 7, and explains the need for a qualified risk-based approach to pollution from the COP15 convention.

Professor Emi Sugawara from Osaka University of Economics and Law, Faculty of International Studies, walks us through the critical development of Japan’s policies concerning business and human rights.

Norm Buckley and Jason Busse from the Michael G. DeGroote Institute for Pain Research & Care in Canada probe the effectiveness of opioid use in Canada as a treatment for chronic noncancer pain.

Professor Saijo Kiyoshi at the Miyagi University of Education explains the work behind the bamboo circulation project of 2020, focusing on bamboo growth and utilization in Satoyama and Satoumi.

The current primary treatment for hypophosphatasia is enzyme replacement therapy; however the development of a new gene therapy drug, ARU-2801, may change the landscape forever.

Tunde Peto, Professor of Clinical Ophthalmology at Queen’s University Belfast, describes the symptoms, causes and treatments for age-related macular degeneration and how the prevalence of the disease could be reduced.

Dr Anthony J. Berdis, Case Comprehensive Cancer Center discusses the future of cancer treatments and anti-cancer drugs.

Professor Allan Doctor from the University of Maryland School of Medicine shares promising developments regarding the creation of safe and effective artificial blood products.

Ragui Assaad and Irene Selwaness examine the increase of women in ICT jobs in Egypt, as well as gender disparities and the efforts to promote ICT employment growth.

Nancy Butler Songer, from the University of Utah, makes a call for collective action to create a new curriculum focused on the design of solutions.

Given the rise in cosmetic procedures involving BoNT-A, cosmetic physician Dr Mary Dingley discusses the therapeutic implications of antibody-induced resistance on future treatment of various conditions, including post-stroke spacticity and pain disorders.

The implementation of innovative data management and data collection tools will help support the sustainable development of EU fisheries; learn how the Fish-X project will support this digital transition of small-scale fisheries.

Dr Charlie Carter from the University of North Carolina at Chapel Hill explores how advances in enzymology and phylogenetics enable biochemical measurements that could map the ancestral development of genetic coding.

In his latest research, Keith A. Hobson, Research Scientist and Professor at Western University, explores why stored fuel is critical to migrating animals, such as monarch butterflies.

Associate Professor of Political Communication, Mariken A.C.G. van der Velden, explores the complexities of political compromise, including its impact on political representation and citizen support.

With a particular focus on glioma, Dr Peter J Houghton from Greehey Children’s Cancer Research Institute outlines the barriers that have hindered the development of effective therapies for childhood solid cancers.

Professor for Ancient History at the University of Zurich, provides an intriguing and instructive analysis of the question of being ‘Roman’ in his most recent ancient history focus.

MMA Global Aqua discuss the transition from the traditional uses of oil and gas to renewable energy in Taiwan, describing the challenges, benefits and skills needed in the transition.